Cerebrovascular disease Cerebrovascular disease , Rehabilitation
Conditions
Interventions
Rehabilitation using IVES+ for 20 minutes per day
Sponsors
Kobayashi Yasuyo
OG Wellness
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Within 1 month of cerebrovascular event (cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage) 2. With upper limb Brunnstrom stage(BRS)2-4 3. Who are 20 years of age or older at the time of obtaining informed consent 4. Whose consent to participate in this clinical study and the informed consent of the patient have has been obtained in writing
Exclusion criteria
Exclusion criteria: 1. Received treatments, such as botulinum therapy, repeated transcranial magnetic stimulation, transcranial direct current stimulation within 90 days of obtaining consent 2. With a history of surgery(including device therapy)or intravenous t-PA for cerebrovascular event (cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage) 3.Cognitive decline(Mini-Mental State Examination(MMSE)is 21 or less) 4.Severe skin symptoms on the affected upper limb 5.Have a history of epileptic seizures 6.With a history of substance abuse or addiction(including alcoholism)at the time of enrollment and within the past year, or patients with complications 7.Using an implantable cardiac stimulator such as a cardiac pacemaker or an implantable assisted heart 8.Using deep brain stimulation 9.With metal(excluding titanium products)implanted in the affected upper limb 10.Who are pregnant or may become pregnant 11.Who are judged by doctors to be inappropriate as research subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the amount of upper limb Fugl-Meyer Assessment(FMA)with respect to pre-intervention value at week 2 or at the time of discontinuation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Changes in the amount of Functional Independence Measure(FIM)with respect to pre-intervention value at the 2nd and 4th weeks 2.Changes in the amount of upper limb BRS with respect to pre-intervention value at the 2nd and 4th weeks 3.Changes in the amount of upper limb FMA with respect to pre-intervention value at the 1st, 3rd, and 4th weeks 4.Changes in the amount of Barthel Index(BI)with respect to pre-intervention value at the 2nd and 4th weeks 5.Changes in grip strength with respect to the pre-intervention value at the 1st, 2nd, 3rd, and 4th weeks 6.Changes in the amount of upper limb Manual Muscle Test(MMT)with respect to pre-intervention value at the 1st, 2nd, 3rd, and 4th weeks | — |
Contacts
Public ContactYasuyo Kobayashi
Nara Medical University Hospital
Outcome results
None listed